| |
| |
|
| Insider
Information: |
Coric Vlad |
| Relationship: |
Director |
| City: |
New Haven |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,794,201 |
|
|
Indirect Shares
|
1,357,668 |
|
|
| Direct
Value |
$69,714,276 |
|
|
|
Indirect Value
|
$52,908,322 |
|
|
| Total
Shares |
3,151,869 |
|
|
| Total
Value |
$122,622,598 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
8
|
0
|
|
Stock
price went up :
|
8
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
8.0
|
0.0
|
| Percentage
Gain/Loss : |
 53.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biohaven Ltd. |
BHVN |
|
2024-04-22 |
1,788,417 |
2024-04-22 |
1,357,668 |
Premium* |
|
|
Revance Therapeutics, Inc. |
RVNC |
Director |
2023-05-03 |
5,784 |
2023-03-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
22 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BHVN |
Biohaven Ltd. |
Chief Executive Officer |
• • – |
2024-04-22 |
4 |
B |
$41.00 |
$4,999,991 |
D/D |
121,951 |
1,788,417 |
0.01 |
% |
|
| BHVN |
Biohaven Ltd. |
Chief Executive Officer |
• • – |
2024-04-05 |
4 |
A |
$0.00 |
$0 |
I/I |
462 |
407,213 |
0 |
- |
|
| BHVN |
Biohaven Ltd. |
Chief Executive Officer |
• • – |
2024-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
232 |
1,666,466 |
0 |
- |
|
| BHVN |
Biohaven Ltd. |
Chief Executive Officer |
• • – |
2024-03-08 |
4 |
A |
$0.00 |
$0 |
I/I |
4,310 |
406,982 |
0 |
- |
|
| BHVN |
Biohaven Ltd. |
Chief Executive Officer |
• • – |
2024-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,162 |
1,666,234 |
0 |
- |
|
| BHVN |
Biohaven Ltd. |
Chief Executive Officer |
• • – |
2024-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
5,400 |
1,662,431 |
0 |
- |
|
| BHVN |
Biohaven Ltd. |
Chief Executive Officer |
• • – |
2024-01-08 |
4 |
A |
$0.00 |
$0 |
I/I |
10,768 |
404,827 |
0 |
- |
|
| BHVN |
Biohaven Ltd. |
Chief Executive Officer |
• • – |
2023-10-05 |
4 |
B |
$22.00 |
$2,500,014 |
D/D |
113,637 |
1,657,031 |
0.01 |
% |
|
| BHVN |
Biohaven Ltd. |
Chief Executive Officer |
• • – |
2023-10-05 |
4 |
B |
$22.00 |
$7,499,976 |
I/I |
340,908 |
833,120 |
0.01 |
% |
|
| RVNC |
Revance Therapeutics, Inc... |
Director |
– • – |
2023-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
589 |
5,784 |
0 |
- |
|
| RVNC |
Revance Therapeutics, Inc... |
Director |
– • – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,195 |
5,195 |
0 |
- |
|
| BHVN |
Biohaven Ltd. |
Chief Executive Officer |
• • – |
2022-10-31 |
4 |
B |
$15.97 |
$411,995 |
D/D |
25,800 |
1,543,394 |
0.01 |
% |
|
| BHVN |
Biohaven Ltd. |
Chief Executive Officer |
• • – |
2022-10-28 |
4 |
B |
$14.87 |
$623,352 |
D/D |
41,930 |
1,517,594 |
0.01 |
% |
|
| BHVN |
Biohaven Ltd. |
Chief Executive Officer |
• • – |
2022-10-28 |
4 |
B |
$14.82 |
$1,482,420 |
I/I |
100,000 |
109,565 |
0.01 |
% |
|
| BHVN |
Biohaven Ltd. |
Chief Executive Officer |
• • – |
2022-10-25 |
4 |
B |
$10.50 |
$8,960,490 |
D/D |
853,380 |
1,475,664 |
0.01 |
% |
|
| BHVN |
Biohaven Ltd. |
Chief Executive Officer |
• • – |
2022-10-05 |
4 |
B |
$8.82 |
$5,009,425 |
I/I |
485,775 |
399,443 |
0.01 |
% |
|
| BHVN |
Biohaven Ltd. |
Chief Executive Officer |
• • – |
2022-10-03 |
4/A |
A |
$0.00 |
$0 |
D/D |
46,025 |
622,284 |
0 |
- |
|
| BHVN |
Biohaven Ltd. |
Chief Executive Officer |
• • – |
2022-10-03 |
4/A |
A |
$0.00 |
$0 |
I/I |
415,445 |
9,565 |
0 |
- |
|
| BHVN |
Biohaven Ltd. |
Chief Executive Officer |
• • – |
2022-10-03 |
4 |
A |
$0.00 |
$0 |
D/D |
567,420 |
567,420 |
0 |
- |
|
| BHVN |
Biohaven Ltd. |
Chief Executive Officer |
• • – |
2022-10-03 |
4 |
OE |
$0.04 |
$869,494 |
D/D |
586,249 |
1,153,669 |
0 |
- |
|
| BHVN |
Biohaven Ltd. |
Chief Executive Officer |
• • – |
2022-10-03 |
4 |
D |
$7.50 |
$869,550 |
D/D |
(115,940) |
1,037,729 |
0 |
- |
|
| BHVN |
Biohaven Ltd. |
Chief Executive Officer |
• • – |
2022-10-03 |
4/A |
A |
$0.00 |
$0 |
D/D |
0 |
569,309 |
0 |
- |
|
22 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
